KAŇKOVÁ, Kateřina, Jan MUŽÍK, Jana KARÁSKOVÁ, Michal BERÁNEK, Dobroslav HÁJEK, Vladimír ZNOJIL, Eva VLKOVÁ and Jiří VÁCHA. Duration of NIDDM and the TNFb NcoI genotype as predictive factors in proliferative diabetic retinopathy. Ophthalmologica. Switzerland: KARGER, 2001, vol. 4, No 215, p. 294-298. ISSN 0030-3755.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Duration of NIDDM and the TNFb NcoI genotype as predictive factors in proliferative diabetic retinopathy
Name in Czech Trvani NIDDM a TNFb NcoI genotyp jsou prediktivni faktory proliferativni diabeticke retinopatie
Authors KAŇKOVÁ, Kateřina (203 Czech Republic), Jan MUŽÍK (203 Czech Republic), Jana KARÁSKOVÁ, Michal BERÁNEK (203 Czech Republic), Dobroslav HÁJEK (203 Czech Republic), Vladimír ZNOJIL (203 Czech Republic), Eva VLKOVÁ (203 Czech Republic) and Jiří VÁCHA (203 Czech Republic).
Edition Ophthalmologica, Switzerland, KARGER, 2001, 0030-3755.
Other information
Original language English
Type of outcome Article in a journal
Field of Study Genetics and molecular biology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 0.843
RIV identification code RIV/00216224:14110/01:00002752
Organization unit Faculty of Medicine
Changed by Changed by: prof. MUDr. Kateřina Kaňková, Ph.D., učo 2524. Changed: 15/2/2005 17:46.
Abstract
The object of the study was to investigate the share of polymorphisms I/D ACE, endothelin-1 4127G/A and TNFb NcoI in the susceptibility to proliferative diabetic retinopathy (PDR) in non-insulin dependent diabetes mellitus (NIDDM). Genotypes were detected by polymerase chain reactions and determined in a set of 246 Caucasian NIDDM subjects with defined PDR status. The relevance of genotypes and clinical characteristics to the PDR occurrence was tested using multiple linear regression models and discrimination analysis. The best predictive value for PDR was given by a combination of two parameters - NIDDM duration and the TNFb genotype (P<1*10-6 and P=1*10-2, respectively) with a correct retrograde prediction of 82.6%. A comparison of the TNFb NcoI allele frequencies revealed no difference between NIDDM and nondiabetic subjects (n=176), but a statistically significant difference was found between PDR and non-PDR NIDDM subjects (after a correction for the number of comparisons P=0.03); allele b2 being associated with PDR. Our results identified the allele variant TNFb2 being associated with PDR in NIDDM. Diabetes duration and the TNFb NcoI genotype were proved to significantly predict PDR occurrence. The TNFb2 allele could be regarded as a separate genetic risk factor that increases the relative incidence of PDR in patients with NIDDM.
Abstract (in Czech)
Zjistili jsme, ze polymorfizmus NcoI v genu pro TNFb je asociovan s proliferativni diabetickou retinopatii u NIDDM. Trvani diabetu a TNFb NcoI genotyp figurovali jako vyznamne prediktivni faktory.
Links
MSM 141100002, plan (intention)Name: Molekulární patofyziologie multigenních chorob
Investor: Ministry of Education, Youth and Sports of the CR, Molecular pathophysiology of multigene diseases
VS96097, research and development projectName: Molekulární patofyziologie vybraných "civilizačních", multigenně podmíněných chorob
Investor: Ministry of Education, Youth and Sports of the CR, Molecular pathophysiology of selected multigenic related to civilization diseases
PrintDisplayed: 1/5/2024 06:35